Listed

Mesa Laboratories Inc: Form 10-Q for the period ended Sep 30, 2021

Filed with the SEC on Nov 4, 2021 and accepted by EDGAR at Nov 4, 2021, 08:02 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2021-09-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2021-07-01 to 2021-09-30$35.8mus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Revenue6 months2021-04-01 to 2021-09-30$70.8mus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Cost of revenue3 months2021-07-01 to 2021-09-30$12.7mus-gaap:CostOfRevenue
Cost of revenue6 months2021-04-01 to 2021-09-30$25.4mus-gaap:CostOfRevenue
Gross profit3 months2021-07-01 to 2021-09-30$23.1mus-gaap:GrossProfit
Gross profit6 months2021-04-01 to 2021-09-30$45.4mus-gaap:GrossProfit
Research and development3 months2021-07-01 to 2021-09-30$2.6mus-gaap:ResearchAndDevelopmentExpense
Research and development6 months2021-04-01 to 2021-09-30$5.4mus-gaap:ResearchAndDevelopmentExpense
Operating income3 months2021-07-01 to 2021-09-30$4.2mus-gaap:OperatingIncomeLoss
Operating income6 months2021-04-01 to 2021-09-30$7.3mus-gaap:OperatingIncomeLoss
Interest expense3 months2021-07-01 to 2021-09-30$815.0kus-gaap:InterestExpense
Interest expense6 months2021-04-01 to 2021-09-30$1.6mus-gaap:InterestExpense
Income tax3 months2021-07-01 to 2021-09-30$823.0kus-gaap:IncomeTaxExpenseBenefit
Income tax6 months2021-04-01 to 2021-09-30$246.0kus-gaap:IncomeTaxExpenseBenefit
Net income3 months2021-07-01 to 2021-09-30$3.7mus-gaap:NetIncomeLoss
Net income6 months2021-04-01 to 2021-09-30$5.7mus-gaap:NetIncomeLoss
Diluted EPS3 months2021-07-01 to 2021-09-30$0.70us-gaap:EarningsPerShareDiluted
Diluted EPS6 months2021-04-01 to 2021-09-30$1.07us-gaap:EarningsPerShareDiluted
Basic EPS3 months2021-07-01 to 2021-09-30$0.71us-gaap:EarningsPerShareBasic
Basic EPS6 months2021-04-01 to 2021-09-30$1.10us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2021-07-01 to 2021-09-305,344,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Diluted shares (weighted)6 months2021-04-01 to 2021-09-305,324,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow6 months2021-04-01 to 2021-09-30$14.0mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure6 months2021-04-01 to 2021-09-30$1.6mus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Dividends paid6 months2021-04-01 to 2021-09-30$1.7mus-gaap:PaymentsOfDividends
Cash and equivalentsAt period end2021-09-30$278.3mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2021-09-30$319.4mus-gaap:AssetsCurrent
Total assetsAt period end2021-09-30$609.1mus-gaap:Assets
Current liabilitiesAt period end2021-09-30$28.7mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2021-09-30$209.7mus-gaap:Liabilities
Shareholders' equityAt period end2021-09-30$399.4mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001437749-21-025180. Last ingested by Listed: Nov 13, 2026, 07:45 ET. Listed shows no prices and gives no investment advice.